Literature DB >> 17632053

PP2A: unveiling a reluctant tumor suppressor.

Marc Mumby1.   

Abstract

Although evidence has suggested that the serine/threonine protein phosphatase 2A (PP2A) might be a tumor suppressor protein, it has been difficult to pin down its role in tumor suppression because it acts in a wide variety of signaling pathways. Recent findings, including work in this issue by Junttila et al. (2007), provide convincing evidence that suppression of PP2A activity cooperates with other oncogenic changes to cause transformation of multiple cell types.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632053     DOI: 10.1016/j.cell.2007.06.034

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  130 in total

1.  Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.

Authors:  Yikun Li; Ping Yue; Xingming Deng; Takeshi Ueda; Rikiro Fukunaga; Fadlo R Khuri; Shi-Yong Sun
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

2.  PP2A:B56{epsilon}, a substrate of caspase-3, regulates p53-dependent and p53-independent apoptosis during development.

Authors:  Zhigang Jin; Lindsay Wallace; Scott Q Harper; Jing Yang
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

3.  Comparisons between murine polyomavirus and Simian virus 40 show significant differences in small T antigen function.

Authors:  Shaida Andrabi; Justin H Hwang; Jennifer Kean Choe; Thomas M Roberts; Brian S Schaffhausen
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

4.  Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells.

Authors:  Rajash Pallai; Aishwarya Bhaskar; Natalie Barnett-Bernodat; Christina Gallo-Ebert; Michelle Pusey; Joseph T Nickels; Lyndi M Rice
Journal:  Tumour Biol       Date:  2015-04-02

5.  Scaling and self-organized criticality in proteins I.

Authors:  J C Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

6.  Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome.

Authors:  Maral Jamshidi; Marjanka K Schmidt; Thilo Dörk; Montserrat Garcia-Closas; Tuomas Heikkinen; Sten Cornelissen; Alexandra J van den Broek; Peter Schürmann; Andreas Meyer; Tjoung-Won Park-Simon; Jonine Figueroa; Mark Sherman; Jolanta Lissowska; Garrett Teoh Hor Keong; Astrid Irwanto; Marko Laakso; Sampsa Hautaniemi; Kristiina Aittomäki; Carl Blomqvist; Jianjun Liu; Heli Nevanlinna
Journal:  Int J Cancer       Date:  2012-10-25       Impact factor: 7.396

7.  PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma.

Authors:  Pietri Puustinen; Melissa R Junttila; Sari Vanhatupa; Anna A Sablina; Melissa E Hector; Kaisa Teittinen; Olayinka Raheem; Kirsi Ketola; Shujun Lin; Juergen Kast; Hannu Haapasalo; William C Hahn; Jukka Westermarck
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

8.  PP2A-dependent disruption of centrosome replication and cytoskeleton organization in Drosophila by SV40 small tumor antigen.

Authors:  S Kotadia; L R Kao; S A Comerford; R T Jones; R E Hammer; T L Megraw
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

9.  Hypoxia-activated Smad3-specific dephosphorylation by PP2A.

Authors:  Pekka T Heikkinen; Marika Nummela; Suvi-Katri Leivonen; Jukka Westermarck; Caroline S Hill; Veli-Matti Kähäri; Panu M Jaakkola
Journal:  J Biol Chem       Date:  2009-12-01       Impact factor: 5.157

10.  Inhibition of Protein Phosphatase 2A Sensitizes Mucoepidermoid Carcinoma to Chemotherapy via the PI3K-AKT Pathway in Response to Insulin Stimulus.

Authors:  Limin Liu; Herui Wang; Jing Cui; Qi Zhang; Wei Zhang; Wanlin Xu; Hao Lu; Shengwen Liu; Shukun Shen; Francia Fang; Lei Li; Wenjun Yang; Zhengping Zhuang; Jiang Li
Journal:  Cell Physiol Biochem       Date:  2018-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.